Apr. 6 at 6:02 PM
$MLEC
Moolec Science ( MLEC +51.80% ▲ ) just unveiled an update.
Moolec opted to rely on its home country corporate governance practices instead of Nasdaq’s requirement for shareholder approval for a change-of-control issuance, as allowed for foreign private issuers. The move consolidates ownership under a single majority investor, strengthening Moolec’s capital position and potentially supporting future growth initiatives while signaling a more centralized control structure for stakeholders.
The most recent analyst rating on MLEC +51.80% ▲ stock is a Sell with a
$6.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.
